South African Treatment Guidelines Need to Consider Viral Load, Not CD4 Count, to Achieve Greater Impact of Treatment as Prevention: Study
March 28, 2014
This article was reported by NAM aidsmap.
NAM aidsmap reported on a study in which the researchers suggest that South Africa should change its recommendation for beginning antiretroviral therapy (ART) to get maximum benefit from treatment as prevention (TasP) by initiating treatment early regardless of CD4 count. In South Africa, guidelines dictate that ART begins with a CD4 count of 350 cells per cubic millimeter (mm3). The researchers contend that data from previous studies, including interim data from the PARTNER study, have shown that HIV-positive individuals with suppressed viral load in serodiscordantView Full Article
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)